UBS Group
RGEN icon

UBS Group’s Repligen RGEN Stock Holding History

UBS Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,200
Closed -$5.98M – 10320
2024
Q3 		$5.98M Buy
+40,200
New +$5.76M ﹤0.01% 2886
2022
Q3 		– Sell
-23,200
Closed -$3.77M – 10825
2022
Q2 		$3.77M Buy
+23,200
New +$3.67M ﹤0.01% 2614

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group's RGEN Position: Q1 2026 in Review

UBS Group increased its Repligen (RGEN) stake by 92% in Q1 2026, buying an estimated $45M and bringing the position to 670,329 shares worth $79M. The position accounts for 0.01% of the portfolio, ranked #1226.

UBS Group first reported a position in RGEN in Q4 2014 and has held it in 46 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • UBS Group held 670,329 shares of Repligen worth $79M as of Q1 2026.
  • UBS Group bought 321,941 Repligen shares in Q1 2026, an estimated $45M.
  • Repligen made up 0.01% of UBS Group's portfolio in Q1 2026, its #1226 holding.
  • UBS Group first reported a position in Repligen in Q4 2014 and has held it in 46 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.